Drug Shortage Report for SANDOZ RIZATRIPTAN ODT

Last updated on 2020-06-22 History
Report ID 113900
Drug Identification Number 02351889
Brand name SANDOZ RIZATRIPTAN ODT
Common or Proper name SANDOZ RIZATRIPTAN ODT
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) RIZATRIPTAN
Strength(s) 10MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size 60DT
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-05-01
Estimated end date 2020-06-19
Actual end date 2020-06-17
Shortage status Resolved
Updated date 2020-06-22
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2020-06-22 French Compare
v8 2020-06-22 English Compare
v7 2020-06-15 French Compare
v6 2020-06-15 English Compare
v5 2020-06-01 French Compare
v4 2020-06-01 English Compare
v3 2020-05-04 French Compare
v2 2020-05-04 English Compare
v1 2020-05-04 English Compare